{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T22:09:02Z","timestamp":1766268542216,"version":"3.37.3"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T00:00:00Z","timestamp":1669680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T00:00:00Z","timestamp":1669680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s11011-022-01131-0","type":"journal-article","created":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T07:53:41Z","timestamp":1669708421000},"page":"1729-1736","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Prevention of post-tips hepatic encephalopathy: The search of the ideal candidate"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7038-9539","authenticated-orcid":false,"given":"Silvia","family":"Nardelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Bellafante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Ridola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Faccioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliviero","family":"Riggio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Gioia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,29]]},"reference":[{"key":"1131_CR1","doi-asserted-by":"publisher","unstructured":"Adlakha N, Russo MW (2020) Outcomes After Transjugular Intrahepatic Portosystemic Shunt in Cirrhotic Patients 70 Years and Older. J Clin Med 9.\u00a0https:\/\/doi.org\/10.3390\/jcm9020381","DOI":"10.3390\/jcm9020381"},{"issue":"6","key":"1131_CR2","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1111\/j.1440-1746.2011.06663.x","volume":"26","author":"M Bai","year":"2011","unstructured":"Bai M, Qi X, Yang Z, Yin Z, Nie Y, Yuan S, Wu K, Han G, Fan D (2011) Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: a systematic review. J Gastroenterol Hepatol 26(6):943\u2013951. https:\/\/doi.org\/10.1111\/j.1440-1746.2011.06663.x","journal-title":"J Gastroenterol Hepatol"},{"key":"1131_CR3","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","volume":"362","author":"NM Bass","year":"2010","unstructured":"Bass NM, Mullen KD, Sanyal A et al (2010) Rifaximin treatment in hepatic encephalopathy. N Engl J Med 362:1071\u20131081","journal-title":"N Engl J Med"},{"issue":"2","key":"1131_CR4","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/hep.26684","volume":"59","author":"P Berlioux","year":"2014","unstructured":"Berlioux P, Robic MA, Poirson H, M\u00e9tivier S, Otal P, Barret C, Lopez F, P\u00e9ron JM, Vinel JP, Bureau C (2014) Pre-transjugular intrahepatic portosystemic shunts (TIPS) prediction of post-TIPS overt hepatic encephalopathy: the critical flicker frequency is more accurate than psychometric tests. Hepatology 59(2):622\u2013629. https:\/\/doi.org\/10.1002\/hep.26684","journal-title":"Hepatology"},{"issue":"4","key":"1131_CR5","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s12072-018-9875-9","volume":"12","author":"RA Bhanji","year":"2018","unstructured":"Bhanji RA, Moctezuma-Velazquez C, Duarte-Rojo A, Ebadi M, Ghosh S, Rose C, Montano-Loza AJ (2018) Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis. Hepatol Int 12(4):377\u2013386. https:\/\/doi.org\/10.1007\/s12072-018-9875-9","journal-title":"Hepatol Int"},{"key":"1131_CR6","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/hep.23383","volume":"51","author":"TD Boyer","year":"2010","unstructured":"Boyer TD, Haskal ZJ (2010) The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension: update 2009. Hepatology 51:306","journal-title":"Hepatology"},{"issue":"2","key":"1131_CR7","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1053\/j.gastro.2003.11.016","volume":"126","author":"C Bureau","year":"2004","unstructured":"Bureau C, Garcia-Pagan JC, Otal P, Pomier-Layrargues G, Chabbert V, Cortez C, Perreault P, P\u00e9ron JM, Abraldes JG, Bouchard L, Bilbao JI, Bosch J, Rousseau H, Vinel JP (2004) Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology 126(2):469\u2013475. https:\/\/doi.org\/10.1053\/j.gastro.2003.11.016","journal-title":"Gastroenterology"},{"issue":"1","key":"1131_CR8","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1053\/j.gastro.2016.09.016","volume":"152","author":"C Bureau","year":"2017","unstructured":"Bureau C, Thabut D, Oberti F, Dharancy S, Carbonell N, Bouvier A, Mathurin P, Otal P, Cabarrou P, P\u00e9ron JM, Vinel JP (2017) Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites. Gastroenterology 152(1):157\u2013163","journal-title":"Gastroenterology"},{"issue":"5","key":"1131_CR9","doi-asserted-by":"publisher","first-page":"633","DOI":"10.7326\/M20-0202","volume":"174","author":"C Bureau","year":"2021","unstructured":"Bureau C, Thabut D, Jezequel C, Archambeaud I, D\u2019Alteroche L, Dharancy S, Borentain P, Oberti F, Plessier A, De Ledinghen V, Ganne-Carri\u00e9 N, Carbonell N, Rousseau V, Sommet A, P\u00e9ron JM, Vinel JP (2021) The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt\u202f: A Randomized Controlled Trial. Ann Intern Med 174(5):633\u2013640. https:\/\/doi.org\/10.7326\/M20-0202","journal-title":"Ann Intern Med"},{"issue":"3","key":"1131_CR10","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1053\/gast.1996.v110.pm8608893","volume":"110","author":"J Cabrera","year":"1996","unstructured":"Cabrera J, Maynar M, Granados R, Gorriz E, Reyes R, Pulido-Duque JM, Rodriguez SanRoman JL, Guerra C, Kravetz D (1996) Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage. Gastroenterology 110(3):832\u2013839","journal-title":"Gastroenterology"},{"key":"1131_CR11","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/S0016-5085(98)70436-6","volume":"114","author":"M Casado","year":"1998","unstructured":"Casado M, Bosch J, Garc\u00eda-Pag\u00e1n JC, Bru C, Ba\u00f1ares R, Bandi JC, Escorsell A, Rodr\u00edguez-L\u00e1iz JM, Gilabert R, Feu F, Schorlemer C, Echenagusia A, Rod\u00e9s J (1998) Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings. Gastroenterology 114:1296\u20131303","journal-title":"Gastroenterology"},{"key":"1131_CR12","doi-asserted-by":"crossref","unstructured":"Cello JP, Ring EJ, Olcott EW, Koch J, Gordon R, Sandhu J, Morgan DR, Ostroff JW, Rockey DC, Bacchetti P, LaBerge J, Lake JR, Somberg K, Doherty C, Davila M, McQuaid K, Wall SD (1997) Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. A randomized, controlled trial. Ann Intern Med 126(11):858\u201365","DOI":"10.7326\/0003-4819-126-11-199706010-00002"},{"issue":"8","key":"1131_CR13","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1007\/s00270-020-02512-7","volume":"43","author":"WM Coronado","year":"2020","unstructured":"Coronado WM, Ju C, Bullen J, Kapoor B (2020) Predictors of Occurrence and Risk of Hepatic Encephalopathy After TIPS Creation: A 15-Year Experience. Cardiovasc Intervent Radiol 43(8):1156\u20131164. https:\/\/doi.org\/10.1007\/s00270-020-02512-7","journal-title":"Cardiovasc Intervent Radiol"},{"key":"1131_CR14","doi-asserted-by":"publisher","unstructured":"Coronado WM, Ju C, Bullen J, Kapoor B (2020) Predictors of Occurrence and Risk of Hepatic Encephalopathy After TIPS Creation: A 15-Year Experience. Cardiovasc Intervent Radiol 43:1156\u20131164.\u00a0https:\/\/doi.org\/10.1007\/s00270-020-02512-7","DOI":"10.1007\/s00270-020-02512-7"},{"issue":"4","key":"1131_CR15","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1002\/hep.28737","volume":"64","author":"G Dam","year":"2016","unstructured":"Dam G, Vilstrup H, Watson H, Jepsen P (2016) Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites. Hepatology 64(4):1265\u20131272. https:\/\/doi.org\/10.1002\/hep.28737","journal-title":"Hepatology"},{"key":"1131_CR16","doi-asserted-by":"publisher","unstructured":"de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C, Baveno VII Faculty (2022) Baveno VII - Renewing consensus in portal hypertension. J Hepatol 76(4):959\u2013974.\u00a0https:\/\/doi.org\/10.1016\/j.jhep.2021.12.022 Erratum in: J Hepatol. 2022 Apr 14","DOI":"10.1016\/j.jhep.2021.12.022"},{"issue":"1","key":"1131_CR17","doi-asserted-by":"publisher","first-page":"e000531","DOI":"10.1136\/bmjgast-2020-000531","volume":"7","author":"K de Wit","year":"2020","unstructured":"de Wit K, Schaapman JJ, Nevens F, Verbeek J, Coenen S, Cuperus FJC, Kramer M, Tjwa ETTL, Mostafavi N, Dijkgraaf MGW, van Delden OM, Beuers UHW, Coenraad MJ, Takkenberg RB (2020) Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt (TIPS): a multicentre randomised, double blind, placebo controlled trial (PEARL trial). BMJ Open Gastroenterol 7(1):e000531","journal-title":"BMJ Open Gastroenterol"},{"key":"1131_CR18","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s10877-009-9167-y","volume":"23","author":"A DeGasperi","year":"2009","unstructured":"DeGasperi A, Corti A, Corso R et al (2009) Transjugular intrahepatic portosystemic shunt (TIPS): the anesthesiological point of view after 150 procedures managed under total intravenous anesthesia. J Clin Monit Comput 23:341\u2013346","journal-title":"J Clin Monit Comput"},{"issue":"3","key":"1131_CR19","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3390\/jcm11030611","volume":"11","author":"S Di Cola","year":"2022","unstructured":"Di Cola S, Nardelli S, Ridola L, Gioia S, Riggio O, Merli M (2022) Ammonia and the Muscle: An Emerging Point of View on Hepatic Encephalopathy. J Clin Med 11(3):611. https:\/\/doi.org\/10.3390\/jcm11030611","journal-title":"J Clin Med"},{"key":"1131_CR20","unstructured":"European Association for the Study of the Liver (2022) Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver. EASL Clinical Practice Guidelines on the management of hepatic encephalopathy. J Hepatol 77(3):807\u2013824"},{"issue":"2","key":"1131_CR21","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1053\/jhep.2002.30418","volume":"35","author":"A Escorsell","year":"2002","unstructured":"Escorsell A, Ba\u00f1ares R, Garc\u00eda-Pag\u00e1n JC, Gilabert R, Moitinho E, Piqueras B, Bru C, Echenagusia A, Granados A, Bosch J (2002) TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial. Hepatology 35(2):385\u2013392","journal-title":"Hepatology"},{"key":"1131_CR22","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Pag\u00e1n JC, Caca K, Bureau C, Laleman W, Appenrodt B, Luca A, Abraldes JG, Nevens F, Vinel JP, M\u00f6ssner J, Bosch J, Early TIPS (Transjugular Intrahepatic Portosystemic Shunt) Cooperative Study Group (2010) Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 362(25):2370\u20139","DOI":"10.1056\/NEJMoa0910102"},{"issue":"5","key":"1131_CR23","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1111\/liv.14050","volume":"39","author":"S Gioia","year":"2019","unstructured":"Gioia S, Merli M, Nardelli S, Lattanzi B, Pitocchi F, Ridola L, Riggio O (2019) The modification of quantity and quality of muscle mass improves the cognitive impairment after TIPS. Liver Int 39(5):871\u2013877. https:\/\/doi.org\/10.1111\/liv.14050","journal-title":"Liver Int"},{"issue":"12","key":"1131_CR24","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1111\/liv.15060","volume":"41","author":"S Gioia","year":"2021","unstructured":"Gioia S, Ridola L, Cristofaro L, Merli M, Faccioli J, Riggio O, Nardelli S (2021) The improvement in body composition including subcutaneous and visceral fat reduces ammonia and hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Liver Int 41(12):2965\u20132973. https:\/\/doi.org\/10.1111\/liv.15060","journal-title":"Liver Int"},{"issue":"6","key":"1131_CR25","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1053\/gast.2002.37073","volume":"123","author":"P Gin\u00e8s","year":"2002","unstructured":"Gin\u00e8s P, Uriz J, Calahorra B, Garcia-Tsao G, Kamath PS, Del Arbol LR, Planas R, Bosch J, Arroyo V, Rod\u00e9s J (2002) Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology 123(6):1839\u20131847","journal-title":"Gastroenterology"},{"issue":"3","key":"1131_CR26","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1080\/003655202317284255","volume":"37","author":"V G\u00fclberg","year":"2002","unstructured":"G\u00fclberg V, Schepke M, Geigenberger G, Holl J, Brensing KA, Waggershauser T, Reiser M, Schild HH, Sauerbruch T, Gerbes AL (2002) Transjugular intrahepatic portosystemic shunting is not superior to endoscopic variceal band ligation for prevention of variceal rebleeding in cirrhotic patients: a randomized, controlled trial. Scand J Gastroenterol 37(3):338\u2013343","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"1131_CR27","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.diii.2020.11.004","volume":"102","author":"Z Huang","year":"2021","unstructured":"Huang Z, Yao Q, Zhu J, He Y, Chen Y, Wu F, Hua T (2021) Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPS) created using covered stents of different diameters: A systematic review and meta-analysis. Diagn Interv Imaging 102(5):279\u2013285. https:\/\/doi.org\/10.1016\/j.diii.2020.11.004","journal-title":"Diagn Interv Imaging"},{"issue":"5","key":"1131_CR28","first-page":"1115","volume":"26","author":"R Jalan","year":"1997","unstructured":"Jalan R, Forrest EH, Stanley AJ, Redhead DN, Forbes J, Dillon JF, MacGilchrist AJ, Finlayson ND, Hayes PC (1997) A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices. Hepatology 26(5):1115\u20131122","journal-title":"Hepatology"},{"key":"1131_CR29","doi-asserted-by":"crossref","unstructured":"Lebrec D, Giuily N, Hadengue A, Vilgrain V, Moreau R, Poynard T, Gadano A, Lassen C, Benhamou JP, Erlinger S (1996) Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. French Group of Clinicians and a Group of Biologists. J Hepatol 25(2):135\u201344","DOI":"10.1016\/S0168-8278(96)80065-1"},{"issue":"2","key":"1131_CR30","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jvir.2018.10.015","volume":"30","author":"DS Lewis","year":"2019","unstructured":"Lewis DS, Lee TH, Konanur M, Ziegler C, Hall MD, Pabon-Ramos WM, Suhocki PV, Smith TP, Kim CY, Choi SS, Ronald J (2019) Proton Pump Inhibitor Use Is Associated with an Increased Frequency of New or Worsening Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Creation. J Vasc Interv Radiol 30(2):163\u2013169. https:\/\/doi.org\/10.1016\/j.jvir.2018.10.015","journal-title":"J Vasc Interv Radiol"},{"issue":"8","key":"1131_CR31","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1055\/s-2007-966591","volume":"39","author":"GH Lo","year":"2007","unstructured":"Lo GH, Liang HL, Chen WC, Chen MH, Lai KH, Hsu PI, Lin CK, Chan HH, Pan HB (2007) A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding. Endoscopy 39(8):679\u2013685","journal-title":"Endoscopy"},{"key":"1131_CR32","doi-asserted-by":"crossref","unstructured":"Lv Y, Chen H, Luo B, Bai W, Li K, Wang Z, Xia D, Guo W, Wang Q, Li X, Yuan J, Cai H, Xia J, Yin Z, Fan D, Han G (2019) Concurrent large spontaneous portosystemic shunt embolization for the prevention of overt hepatic encephalopathy after TIPS: A randomized controlled trial. Hepatology 76(3):676\u2013688","DOI":"10.1002\/hep.32453"},{"key":"1131_CR33","doi-asserted-by":"crossref","unstructured":"Lv Y, Qi X, He C, Wang Z, Yin Z, Niu J, Guo W, Bai W, Zhang H, Xie H, Yao L, Wang J, Li T, Wang Q, Chen H, Liu H, Wang E, Xia D, Luo B, Li X, Yuan J, Han N, Zhu Y, Xia J, Cai H, Yang Z, Wu K, Fan D, Han G, PVT-TIPS Study Group (2018) Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial. Gut 67(12):2156\u20132168","DOI":"10.1136\/gutjnl-2017-314634"},{"key":"1131_CR34","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.hepres.2004.09.003","volume":"30","author":"Y Mamiya","year":"2004","unstructured":"Mamiya Y, Kanazawa H, Kimura Y et al (2004) Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Hepatol Res 30:162\u2013168","journal-title":"Hepatol Res"},{"issue":"2","key":"1131_CR35","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s11011-012-9365-z","volume":"28","author":"M Merli","year":"2013","unstructured":"Merli M, Giusto M, Lucidi C, Giannelli V, Pentassuglio I, Di Gregorio V, Lattanzi B, Riggio O (2013) Muscle depletion increases the risk of overt and minimal hepatic encephalopathy: results of a prospective study. Metab Brain Dis 28(2):281\u2013284. https:\/\/doi.org\/10.1007\/s11011-012-9365-z","journal-title":"Metab Brain Dis"},{"issue":"5","key":"1131_CR36","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1002\/hep.510230516","volume":"23","author":"M Merli","year":"1996","unstructured":"Merli M, Riggio O, Dally L (1996) Does malnutrition affect survival in cirrhosis? PINC (Policentrica Italiana Nutrizione Cirrosi). Hepatology 23(5):1041\u20131046. https:\/\/doi.org\/10.1002\/hep.510230516","journal-title":"Hepatology"},{"key":"1131_CR37","doi-asserted-by":"crossref","unstructured":"Merli M, Salerno F, Riggio O, de Franchis R, Fiaccadori F, Meddi P, Primignani M, Pedretti G, Maggi A, Capocaccia L, Lovaria A, Ugolotti U, Salvatori F, Bezzi M, Rossi P (1998) Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. Gruppo Italiano Studio TIPS (G.I.S.T.). Hepatology 27(1):48\u201353","DOI":"10.1002\/hep.510270109"},{"key":"1131_CR38","doi-asserted-by":"publisher","unstructured":"Miraglia R, Maruzzelli L, Di Piazza A, Mamone G, Caruso S, Gentile G, Tuzzolino F, Floridia G, Petridis I, Volpes R, Luca A (2019) Transjugular Intrahepatic Portosystemic Shunt Using the New Gore Viatorr Controlled Expansion Endoprosthesis: Prospective, Single-Center, Preliminary Experience. Cardiovasc Intervent Radiol 42:78\u201386.\u00a0https:\/\/doi.org\/10.1007\/s00270-018-2040-y","DOI":"10.1007\/s00270-018-2040-y"},{"key":"1131_CR39","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejrad.2017.01.032","volume":"89","author":"A Mollaiyan","year":"2017","unstructured":"Mollaiyan A, Bettinger D, R\u00f6ssle M (2017) The underdilation of nitinol stents at TIPS implantation: Solution or illusion? Eur J Radiol 89:123\u2013128. https:\/\/doi.org\/10.1016\/j.ejrad.2017.01.032","journal-title":"Eur J Radiol"},{"issue":"2","key":"1131_CR40","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.dld.2018.11.035","volume":"51","author":"S Montagnese","year":"2019","unstructured":"Montagnese S, Russo FP, Amodio P, Burra P, Gasbarrini A, Loguercio C, Marchesini G, Merli M, Ponziani FR, Riggio O, Scarpignato C (2019) Hepatic encephalopathy 2018: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF). Dig Liver Dis 51(2):190\u2013205. https:\/\/doi.org\/10.1016\/j.dld.2018.11.035","journal-title":"Dig Liver Dis"},{"key":"1131_CR41","doi-asserted-by":"publisher","unstructured":"Montano-Loza AJ, Angulo P, Meza-Junco J, Prado CM, Sawyer MB, Beaumont C, Esfandiari N, Ma M, Baracos VE (2016) Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis. J Cachexia Sarcopenia Muscle 7(2):126\u201335.\u00a0https:\/\/doi.org\/10.1002\/jcsm.12039","DOI":"10.1002\/jcsm.12039"},{"key":"1131_CR42","doi-asserted-by":"publisher","unstructured":"Montano-Loza AJ, Meza-Junco J, Prado CM, Lieffers JR, Baracos VE, Bain VG, Sawyer MB (2012) Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol 10(2):166\u201373, 173.e1.\u00a0https:\/\/doi.org\/10.1016\/j.cgh.2011.08.028","DOI":"10.1016\/j.cgh.2011.08.028"},{"issue":"1","key":"1131_CR43","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s00535-010-0282-9","volume":"46","author":"Y Narahara","year":"2011","unstructured":"Narahara Y, Kanazawa H, Fukuda T, Matsushita Y, Harimoto H, Kidokoro H, Katakura T, Atsukawa M, Taki Y, Kimura Y, Nakatsuka K, Sakamoto C (2011) Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a prospective randomized trial. J Gastroenterol 46(1):78\u201385","journal-title":"J Gastroenterol"},{"issue":"4","key":"1131_CR44","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/ajg.2016.29","volume":"111","author":"S Nardelli","year":"2016","unstructured":"Nardelli S, Gioia S, Pasquale C, Pentassuglio I, Farcomeni A, Merli M, Salvatori FM, Nikolli L, Torrisi S, Greco F, Nicoletti V, Riggio O (2016) Cognitive Impairment Predicts The Occurrence Of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt. Am J Gastroenterol 111(4):523\u2013528. https:\/\/doi.org\/10.1038\/ajg.2016.29","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"1131_CR45","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/hep.30304","volume":"70","author":"S Nardelli","year":"2019","unstructured":"Nardelli S, Gioia S, Ridola L, Farcomeni A, Merli M, Riggio O (2019) Proton Pump Inhibitors Are Associated With Minimal and Overt Hepatic Encephalopathy and Increased Mortality in Patients With Cirrhosis. Hepatology 70(2):640\u2013649. https:\/\/doi.org\/10.1002\/hep.30304","journal-title":"Hepatology"},{"issue":"5","key":"1131_CR46","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1002\/hep.30692","volume":"70","author":"S Nardelli","year":"2019","unstructured":"Nardelli S, Lattanzi B, Merli M, Farcomeni A, Gioia S, Ridola L, Riggio O (2019) Muscle Alterations Are Associated With Minimal and Overt Hepatic Encephalopathy in Patients With Liver Cirrhosis. Hepatology 70(5):1704\u20131713. https:\/\/doi.org\/10.1002\/hep.30692","journal-title":"Hepatology"},{"issue":"6","key":"1131_CR47","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cgh.2016.10.028","volume":"15","author":"S Nardelli","year":"2017","unstructured":"Nardelli S, Lattanzi B, Torrisi S, Greco F, Farcomeni A, Gioia S, Merli M, Riggio O (2017) Sarcopenia Is Risk Factor for Development of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement. Clin Gastroenterol Hepatol 15(6):934\u2013936. https:\/\/doi.org\/10.1016\/j.cgh.2016.10.028","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1131_CR48","doi-asserted-by":"publisher","unstructured":"Plauth M, Merli M, Kondrup J, Weimann A, Ferenci P, M\u00fcller MJ; ESPEN Consensus Group (1997) ESPEN guidelines for nutrition in liver disease and transplantation. Clin Nutr 16(2):43\u201355.\u00a0https:\/\/doi.org\/10.1016\/s0261-5614(97)80022-2","DOI":"10.1016\/s0261-5614(97)80022-2"},{"issue":"3","key":"1131_CR49","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1136\/gut.48.3.390","volume":"48","author":"G Pomier-Layrargues","year":"2001","unstructured":"Pomier-Layrargues G, Villeneuve JP, Desch\u00eanes M, Bui B, Perreault P, Fenyves D, Willems B, Marleau D, Bilodeau M, Lafortune M, Dufresne MP (2001) Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial. Gut 48(3):390\u2013396","journal-title":"Gut"},{"key":"1131_CR50","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.1016\/S0168-8278(17)30360-4","volume":"66","author":"M Praktiknjo","year":"2017","unstructured":"Praktiknjo M, Lehmann J, Fischer S, Strassburg CP, Meyer C, Trebicka J (2017) Novel diameter controlled expansion TIPS (Viatorr CX\u00ae) graft reduces readmission compared to regular covered TIPS graft and bare metal graft. J Hepatol 66:S48\u2013S49. https:\/\/doi.org\/10.1016\/S0168-8278(17)30360-4","journal-title":"J Hepatol"},{"issue":"11","key":"1131_CR51","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1111\/j.1572-0241.2008.02102.x","volume":"103","author":"O Riggio","year":"2008","unstructured":"Riggio O, Angeloni S, Salvatori FM, De Santis A, Cerini F, Farcomeni A, Attili AF, Merli M (2008) Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts. Am J Gastroenterol 103(11):2738\u20132746. https:\/\/doi.org\/10.1111\/j.1572-0241.2008.02102.x","journal-title":"Am J Gastroenterol"},{"key":"1131_CR52","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.jhep.2004.12.028","volume":"42","author":"O Riggio","year":"2005","unstructured":"Riggio O, Masini A, Efrati C et al (2005) Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study. J Hepatol 42:674\u2013679","journal-title":"J Hepatol"},{"key":"1131_CR53","doi-asserted-by":"crossref","unstructured":"Riggio O, Merli M, Pedretti R et al (1996) Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Incidence and risk factors. Dig Dis Sci 41:578\u201384","DOI":"10.1007\/BF02282344"},{"issue":"1","key":"1131_CR54","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cld.2011.12.008","volume":"16","author":"O Riggio","year":"2012","unstructured":"Riggio O, Nardelli S, Moscucci F, Pasquale C, Ridola L, Merli M (2012) Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Clin Liver Dis 16(1):133\u2013146","journal-title":"Clin Liver Dis"},{"issue":"2","key":"1131_CR55","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jhep.2010.02.033","volume":"53","author":"O Riggio","year":"2010","unstructured":"Riggio O, Ridola L, Angeloni S, Cerini F, Pasquale C, Attili AF, Fanelli F, Merli M, Salvatori FM (2010) Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: results of a randomized controlled trial. J Hepatol 53(2):267\u2013272. https:\/\/doi.org\/10.1016\/j.jhep.2010.02.033","journal-title":"J Hepatol"},{"key":"1131_CR56","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.dld.2009.11.007","volume":"42","author":"O Riggio","year":"2010","unstructured":"Riggio O, Ridola L, Lucidi C et al (2010) Emerging issues in the use of transjugular in- trahepatic portosystemic shunt (TIPS) for management of portal hypertension: time to update the guidelines? Dig Liver Dis 42:462\u2013467","journal-title":"Dig Liver Dis"},{"key":"1131_CR57","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/0016-5085(78)90851-X","volume":"75","author":"L Rikkers","year":"1978","unstructured":"Rikkers L, Jenko P, Rudman D et al (1978) Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism. Gastroenterology 75:462\u2013469","journal-title":"Gastroenterology"},{"key":"1131_CR58","doi-asserted-by":"crossref","unstructured":"R\u00f6sch J, Keller FS (2001) Transjugular intrahepatic portosystemic shunt: present status, comparison with endoscopic therapy and shunt surgery, and future prospectives. World J Surg 25:337\u201346","DOI":"10.1007\/s002680020380"},{"key":"1131_CR59","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0140-6736(89)90201-8","volume":"2","author":"M Rossle","year":"1989","unstructured":"Rossle M, Richter GM, Noldge G et al (1989) New non-operative treatment for variceal haemorrhage. Lancet 2:153","journal-title":"Lancet"},{"issue":"9058","key":"1131_CR60","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/S0140-6736(96)08189-5","volume":"349","author":"M R\u00f6ssle","year":"1997","unstructured":"R\u00f6ssle M, Deibert P, Haag K, Ochs A, Olschewski M, Siegerstetter V, Hauenstein KH, Geiger R, Stiepak C, Keller W, Blum HE (1997) Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. Lancet 349(9058):1043\u20131049","journal-title":"Lancet"},{"issue":"23","key":"1131_CR61","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1056\/NEJM200006083422303","volume":"342","author":"M R\u00f6ssle","year":"2000","unstructured":"R\u00f6ssle M, Ochs A, G\u00fclberg V, Siegerstetter V, Holl J, Deibert P, Olschewski M, Reiser M, Gerbes AL (2000) A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 342(23):1701\u20131707","journal-title":"N Engl J Med"},{"issue":"7","key":"1131_CR62","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1080\/02841850600806324","volume":"47","author":"M R\u00f6ssle","year":"2006","unstructured":"R\u00f6ssle M, Siegerstetter V, Euringer W, Olschewski M, Kromeier J, Kurz K, Langer M (2006) The use of a polytetrafluoroethylene-covered stent graft for transjugular intrahepatic portosystemic shunt (TIPS): Long-term follow-up of 100 patients. Acta Radiol 47(7):660\u2013666","journal-title":"Acta Radiol"},{"key":"1131_CR63","first-page":"215","volume":"15","author":"N Saad","year":"2016","unstructured":"Saad N, Rude MK, Darcy M, Hanin JB, Wentworth A, Korenblat KM (2016) Older age is associated with increased early mortality after transjugular intrahepatic portosystemic shunt. Ann Hepatol 15:215\u2013221","journal-title":"Ann Hepatol"},{"issue":"3","key":"1131_CR64","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/hep.20364","volume":"40","author":"F Salerno","year":"2004","unstructured":"Salerno F, Merli M, Riggio O, Cazzaniga M, Valeriano V, Pozzi M, Nicolini A, Salvatori F (2004) Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites. Hepatology 40(3):629\u2013635","journal-title":"Hepatology"},{"key":"1131_CR65","first-page":"46","volume":"20","author":"AJ Sanjal","year":"1994","unstructured":"Sanjal AJ, Freedman A, Shiffman ML et al (1994) Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study. Hepatology 20:46\u201355","journal-title":"Hepatology"},{"key":"1131_CR66","doi-asserted-by":"crossref","unstructured":"Sanyal AJ, Freedman AM, Luketic VA, Purdum PP 3rd, Shiffman ML, Cole PE, Tisnado J, Simmons S (1997) Transjugular intrahepatic portosystemic shunts compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage. A randomized, controlled trial. Ann Intern Med 126(11):849\u201357","DOI":"10.7326\/0003-4819-126-11-199706010-00001"},{"key":"1131_CR67","doi-asserted-by":"crossref","unstructured":"Sanyal AJ, Genning C, Reddy KR, Wong F, Kowdley KV, Benner K, McCashland T, North American Study for the Treatment of Refractory Ascites Group (2003) The North American Study for the Treatment of Refractory Ascites. Gastroenterology 124(3):634\u201341","DOI":"10.1053\/gast.2003.50088"},{"issue":"5","key":"1131_CR68","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1053\/gast.1997.v113.pm9352865","volume":"113","author":"P Sauer","year":"1997","unstructured":"Sauer P, Theilmann L, Stremmel W, Benz C, Richter GM, Stiehl A (1997) Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding. Gastroenterology 113(5):1623\u20131631","journal-title":"Gastroenterology"},{"key":"1131_CR69","doi-asserted-by":"crossref","unstructured":"Sauer P, Hansmann J, Richter GM, Stremmel W, Stiehl A (2002) Endoscopic variceal ligation plus propranolol vs. transjugular intrahepatic portosystemic stent shunt: a long-term randomized trial. Endoscopy 34(9):690\u20137","DOI":"10.1055\/s-2002-33565"},{"issue":"2","key":"1131_CR70","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3390\/jcm9020567","volume":"9","author":"P Schindler","year":"2020","unstructured":"Schindler P, Seifert L, Masthoff M, Riegel A, K\u00f6hler M, Wilms C, Schmidt HH, Heinzow H, Wildgruber M (2020) TIPS Modification in the Management of Shunt-Induced Hepatic Encephalopathy: Analysis of Predictive Factors and Outcome with Shunt Modification. J Clin Med 9(2):567. https:\/\/doi.org\/10.3390\/jcm9020567","journal-title":"J Clin Med"},{"key":"1131_CR71","doi-asserted-by":"crossref","unstructured":"Shiffman ML, Jeffers L, Hoofnagle JH, et al (1995) Role of transjugular intrahepatic portosystemic shunt treatment of portal hypertension and its complication: conference sponsored by the National Digestive Diseases Advisory Board. Hepatology 22:1591\u20137","DOI":"10.1002\/hep.1840220536"},{"key":"1131_CR72","first-page":"549","volume":"90","author":"KA Somberg","year":"1995","unstructured":"Somberg KA, Riegler JL, LaBerge JM et al (1995) Hepatic encephalopathy after trans- jugular intrahepatic portosystemic shunt: incidence and risk factors. Am J Gas- Troenterol 90:549\u2013555","journal-title":"Am J Gas- Troenterol"},{"key":"1131_CR73","doi-asserted-by":"crossref","unstructured":"Tantai X, Liu Y, Yeo YH, Praktiknjo M, Mauro E, Hamaguchi Y, Engelmann C, Zhang P, Jeong JY, van Vugt JLA, Xiao H, Deng H, Gao X, Ye Q, Zhang J, Yang L, Cai Y, Liu Y, Liu N, Li Z, Han T, Kaido T, Sohn JH, Strassburg C, Berg T, Trebicka J, Hsu YC, IJzermans JNM, Wang J, Su GL, Ji F, Nguyen MH (2022) Effect of sarcopenia on survival in patients with cirrhosis: A meta-analysis. J Hepatol 76(3):588\u2013599","DOI":"10.1016\/j.jhep.2021.11.006"},{"issue":"13","key":"1131_CR74","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1016\/j.cgh.2019.03.042","volume":"17","author":"J Trebicka","year":"2019","unstructured":"Trebicka J, Bastgen D, Byrtus J, Praktiknjo M, Terstiegen S, Meyer C, Thomas D, Fimmers R, Treitl M, Euringer W, Sauerbruch T, R\u00f6ssle M (2019) Smaller-Diameter Covered Transjugular Intrahepatic Portosystemic Shunt Stents Are Associated With Increased Survival. Clin Gastroenterol Hepatol 17(13):2793-2799.e1. https:\/\/doi.org\/10.1016\/j.cgh.2019.03.042","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1131_CR75","doi-asserted-by":"publisher","unstructured":"Tripathi D, Stanley AJ, Hayes PC, Travis S, Armstrong MJ, Tsochatzis EA, Rowe IA, Roslund N, Ireland H, Lomax M, Leithead JA, Mehrzad H, Aspinall RJ, McDonagh J, Patch D (2020) Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension. Gut 69(7):1173\u20131192.\u00a0https:\/\/doi.org\/10.1136\/gutjnl-2019-320221","DOI":"10.1136\/gutjnl-2019-320221"},{"issue":"1","key":"1131_CR76","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1053\/j.gastro.2016.09.007","volume":"152","author":"CF Tsai","year":"2017","unstructured":"Tsai CF, Chen MH, Wang YP, Chu CJ, Huang YH, Lin HC, Hou MC, Lee FY, Su TP, Lu CL (2017) Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study. Gastroenterology 152(1):134\u2013141. https:\/\/doi.org\/10.1053\/j.gastro.2016.09.007","journal-title":"Gastroenterology"},{"issue":"2","key":"1131_CR77","doi-asserted-by":"publisher","first-page":"472","DOI":"10.2214\/ajr.185.2.01850472","volume":"185","author":"C Vignali","year":"2005","unstructured":"Vignali C, Bargellini I, Grosso M, Passalacqua G, Maglione F, Pedrazzini F, Filauri P, Niola R, Cioni R, Petruzzi P (2005) TIPS with expanded polytetrafluoroethylene-covered stent: results of an Italian multicenter study. AJR Am J Roentgenol 185(2):472\u2013480","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"1131_CR78","doi-asserted-by":"publisher","first-page":"21011","DOI":"10.1038\/srep21011","volume":"15","author":"L Wang","year":"2016","unstructured":"Wang L, Xiao Z, Yue Z, Zhao H, Fan Z, Zhao M, He F, Dai S, Qiu B, Yao J, Lin Q, Dong X, Liu F (2016) Efficacy of covered and bare stent in TIPS for cirrhotic portal hypertension: A single-center randomized trial. Sci Rep 15(6):21011","journal-title":"Sci Rep"},{"issue":"3","key":"1131_CR79","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.jhep.2017.05.006","volume":"67","author":"Q Wang","year":"2017","unstructured":"Wang Q, Lv Y, Bai M, Wang Z, Liu H, He C, Niu J, Guo W, Luo B, Yin Z, Bai W, Chen H, Wang E, Xia D, Li X, Yuan J, Han N, Cai H, Li T, Xie H, Xia J, Wang J, Zhang H, Wu K, Fan D, Han G (2017) Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding. J Hepatol 67(3):508\u2013516. https:\/\/doi.org\/10.1016\/j.jhep.2017.05.006","journal-title":"J Hepatol"},{"key":"1131_CR80","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1053\/gast.1997.v112.pm9041252","volume":"112","author":"F Wong","year":"1997","unstructured":"Wong F, Sniderman K, Liu P et al (1997) The mechanism of the initial natriuresis after transjugular intrahepatic portosystemic shunt. Gastroenterology 112:899\u2013907","journal-title":"Gastroenterology"},{"issue":"3","key":"1131_CR81","doi-asserted-by":"publisher","first-page":"301","DOI":"10.15403\/jgld.2014.1121.243.yao","volume":"24","author":"J Yao","year":"2015","unstructured":"Yao J, Zuo L, An G, Yue Z, Zhao H, Wang L, Liu F (2015) Risk Factors for Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Patients with Hepatocellular Carcinoma and Portal Hypertension. J Gastrointestin Liver Dis 24(3):301\u2013307. https:\/\/doi.org\/10.15403\/jgld.2014.1121.243.yao","journal-title":"J Gastrointestin Liver Dis"},{"issue":"1","key":"1131_CR82","doi-asserted-by":"publisher","first-page":"9381","DOI":"10.1038\/s41598-020-65227-2","volume":"10","author":"X Yin","year":"2020","unstructured":"Yin X, Zhang F, Guo H, Peng C, Zhang W, Xiao J, Wang Y, Zou X, Zhang M, Zhuge Y (2020) A nomogram to predict the risk of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in Cirrhotic Patients. Sci Rep 10(1):9381. https:\/\/doi.org\/10.1038\/s41598-020-65227-2","journal-title":"Sci Rep"},{"key":"1131_CR83","doi-asserted-by":"publisher","unstructured":"Zuckerman DA, Darcy MD, Bocchini TP, Hildebolt CF (1997) Encephalopathy after transjugular intrahepatic portosystemic shunting: analysis of incidence and potential risk factors. AJR Am J Roentgenol 169:1727\u20131731.\u00a0https:\/\/doi.org\/10.2214\/ajr.169.6","DOI":"10.2214\/ajr.169.6"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-022-01131-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-022-01131-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-022-01131-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T14:24:06Z","timestamp":1684160646000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-022-01131-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,29]]},"references-count":83,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["1131"],"URL":"https:\/\/doi.org\/10.1007\/s11011-022-01131-0","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"type":"print","value":"0885-7490"},{"type":"electronic","value":"1573-7365"}],"subject":[],"published":{"date-parts":[[2022,11,29]]},"assertion":[{"value":"26 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate and consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}